I wonder what the result would be of vastly reducing regulatory approval requirements, but in exchange giving pharmaceutical companies unlimited liability. So, sure, put that poorly-tested drug out there, but every person who has horrifying side-effects is going to sue you for millions
I don't think lawsuits are the best "first line of defense" for protecting consumers against harmful drugs. Because the usual measure of damages is the cost of harm, the actual recovery (once discounted by litigation risk and diminished by legal fees), is a fraction of the cost of the harm. That discount is particularly significant in medical cases, because proving causation is very difficult (how do you know that this drug caused your dad's heart attack instead of the three others he was taking?).
Moreover, drug-related litigation these days relies heavily on the factual record developed by clinical trials and FDA investigations. Class action lawsuits are often precipitated by an FDA action. E.g. major litigation like Fen-Phen and Vioxx, that netted tens of billions of dollars in recovery for consumers, were kicked off by FDA recalls. Individual litigants are poorly positioned to develop the scientific record necessary to support a lawsuit.
Perhaps an advanced society should involve one generation taking care of the next instead of the government?
Not really. Indeed, given voting patterns it's more like the older generation empowers enforcers to rob the younger generation and then empowers others to use those stolen funds to buy them drugs.
What "insurance laws" "subsidize" drug costs?
The cost of regulatory approval is high, but that's justified because the economic cost of a bad or even just ineffective drug piles up very quickly. Reduce the life expectancy of 1,000 people by 10 years (or give them an ineffective alternative to a drug that could extend their life by 10 years) and that's a billion dollars of damages right there. Is there a cheaper solution than extensive clinical trials that accomplished the same result?
It's not clear there is. Remember, what really makes approval so expensive is that most candidate drugs don't get approval. So the investment into all the drugs that don't work has to be recouped from the ones that do. But the fact that so many drugs fail at the clinic trial stage suggests we don't have better ways of predicting whether drugs will be safe and effective. Drug companies don't invest into drugs that don't pass approval for funsies. If they could determine a drug wasn't going to pass approval before the clinical trials, they'd do it. It'd be pure profit for them. Also, the fact that so many drugs don't pass approval suggests that the FDA is keeping a bunch of ineffective and harmful drugs off the market. The cost of getting rid of the FDA has to account for the cost of those bad and ineffective drugs.
Also, getting rid of these things would not make the drug industry a "free market." In any advanced society, the government will pay for drugs for elderly and poor people. That creates an entity that can exercise monopsony power. Get rid of patents on drugs, then you get the free rider effect undermining R&D. And get rid of the FDA, and you end up with a market with huge information asymmetries that allow drug manufacturers to sell products that don't work without customers having a way to know that. These would destroy any hope of a functioning competitive market. You can't talk about markets while pretending only the parts of economics that comport with your world view exist.